Claret Asset Management Corp Novo Nordisk A S Transaction History

Claret Asset Management Corp

$562 Million
Q2 2024

A detailed history of Claret Asset Management Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Claret Asset Management Corp holds 7,291 shares of NVO stock, worth $880,461. This represents 0.19% of its overall portfolio holdings.

Number of Shares

7,291

Previous 7,966 8.47%

Holding current value

$880,461

Previous $1.02 Million 1.76%

% of portfolio

0.19%

Previous 0.17%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $82,829 - $99,164	-675 Reduced 8.47%	7,291 $1.04 Million
Q1 2024 Apr 29, 2024	BUY	$102.11 - $135.92 $66,371 - $88,347	650 Added 8.88%	7,966 $1.02 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $335,659 - $736,502	3,691 Added 101.82%	7,316 $665,000
Q4 2021 Feb 07, 2022	SELL	$95.88 - $117.08 $3,451 - $4,214	-36 Reduced 0.98%	3,625 $406,000
Q4 2020 Feb 02, 2021	SELL	$63.89 - $73.8 $19,678 - $22,730	-308 Reduced 7.76%	3,661 $256,000
Q2 2020 Aug 06, 2020	SELL	$58.54 - $67.94 $233,574 - $271,080	-3,990 Reduced 50.13%	3,969 $260,000
Q1 2020 Apr 06, 2020	SELL	$49.46 - $64.78 $84,329 - $110,449	-1,705 Reduced 17.64%	7,959 $479,000
Q4 2019 Jan 07, 2020	SELL	$49.86 - $58.26 $3,440 - $4,019	-69 Reduced 0.71%	9,664 $559,000
Q3 2019 Oct 11, 2019	SELL	$47.54 - $53.43 $2,234 - $2,511	-47 Reduced 0.48%	9,733 $503,000
Q1 2019 Apr 29, 2019	BUY	$46.36 - $52.63 $2,178 - $2,473	47 Added 0.48%	9,780 $512,000
Q3 2018 Oct 30, 2018	BUY	$46.76 - $51.24 $42,271 - $46,320	904 Added 10.24%	9,733 $459,000
Q2 2018 Aug 13, 2018	BUY	$44.29 - $50.42 $199,305 - $226,890	4,500 Added 103.95%	8,829 $407,000
Q4 2017 Mar 27, 2018	BUY	$47.53 - $53.73 $205,757 - $232,597	4,329	4,329 $232,000

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $273B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.

Account

Claret Asset Management Corp Novo Nordisk A S Transaction History